News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...
Kate Beckinsale addressed her dramatic weight loss after a fan weighed in on her appearance via social media. On Tuesday, the ...
GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...
By Andrew Silver SHANGHAI (Reuters) -Chinese drugmaker Innogen expects to complete a late-stage clinical trial of its ...
Kylie Kelce said she's been feeding her husband, Jason Kelce, doughnuts and other treats amid his weight-loss competition ...
Now, after gaining all that weight back due to not being able to continually and severely restrict my diet, I am using ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...